Meet Dr. Stacey Stein

Transcript

• 00:00Hi, my name is Stacy Stein.
• 00:03I'm an associate professor
• 00:05of medicine at Yale.
• 00:06I've been here since 2010 and I focus
• 00:09in GI cancers specifically with
• 00:11a focus in hepatobiliary cancers.
• 00:13I think I always knew I
• 00:15wanted to go into medicine,
• 00:17but in thinking about when did
• 00:20I first really think about
• 00:22oncology when I was in college?
• 00:24One of my grandmothers was diagnosed
• 00:27with pancreatic cancer and it was
• 00:29a very tough year for our family.
• 00:32Uhm, and I think it really connected
• 00:35me to really appreciating how the
• 00:38science and new discoveries could
• 00:41help these types of patients.
• 00:44I think that's when the seed was
• 00:46kind of first planted for me.
• 00:48It's a tough position to be in
• 00:50when there's a question of a cancer
• 00:53diagnosis and people are waiting for a plan.
• 00:56We try to put people at ease,
• 00:59answer all of their questions,
• 01:00come up with a plan together.
• 01:02Really think about all of the options,
• 01:05but just to know that the team
• 01:07is here to take care of you and
• 01:10you know we really want to know
• 01:12what's important to you,
• 01:14what questions you have and what we
• 01:16can do to make things easier for you.
• 01:19I think it's important to
• 01:21have your support team there,
• 01:23and cancer care is really a
• 01:25full team that's involved, so.
• 01:27It's often the patient and
• 01:29their team at home,
• 01:30and then the team that you have here at
• 01:34the hospital and we all work together.
• 01:37We have many studies open for
• 01:39patients with GI cancers,
• 01:41and I've been mostly focused in
• 01:43developing new clinical trials
• 01:45and opening studies for patients
• 01:47with hepatobiliary cancers,
• 01:48and that has been very rewarding and
• 01:51so just in the last couple of years,
• 01:55there's been multiple new therapies
• 01:57for liver cancer.
• 01:58We had participated in one of the
• 02:01groundbreaking phase one studies
• 02:03of looking at the combination
• 02:06of atezolizumab and bevacizumab
• 02:08for liver cancer patients,
• 02:10and just this past year that drug
• 02:13combination was approved and it's
• 02:15just been really rewarding to see
• 02:18the treatment options changing
• 02:20and improving for our patients.